The Ophthalmology Practice Market in 2026

Global demand for eye care keeps climbing for reasons that have nothing to do with marketing spend: an aging population needs more cataract surgery, more glaucoma management and more diabetic retinopathy screening every year. The global ophthalmology market was valued at $67.85B in 2025 and is projected to reach $94.36B by 2030, a 6.76% compound annual growth rate, according to Precedence Research, 2025. A narrower but faster-growing slice of the market — the software layer practices run on — is worth watching too: the ophthalmology practice management software segment alone is expected to grow from $1.85B in 2025 to $3.95B by 2035, a 7.9% CAGR, according to Vantage Market Research — a signal of where administrative and billing spend is heading over the next decade.

None of that growth flows automatically to a new practice. It flows to whichever practice wins the referral relationships, the payer contracts and the surgical volume in its specific market.

Who Actually Buys Ophthalmology Care

Patients arrive through three distinct doors, and a plan that treats them as one undifferentiated audience under-forecasts revenue on all three:

• Medical and surgical patients referred by optometrists and primary care physicians for cataract, glaucoma, retinal disease and diabetic eye complications — the highest-volume, insurance-reimbursed segment
• Self-pay refractive and premium-lens patients seeking LASIK, PRK or premium intraocular lenses, who shop on outcomes and continuity of care rather than price alone
• Vision-plan patients arriving through employer vision benefit networks for routine comprehensive exams, a channel that regularly converts into medical care once pathology is found

The co-management relationship with local optometrists is the single most valuable acquisition channel in ophthalmology. A new practice that hasn't built referral relationships with a handful of optometry practices before opening day is starting with an empty pipeline — referral trust takes 6–12 months to build and should start well before the lease is signed.

Independent Practices vs. the Roll-Up Chains

Private equity has consolidated a meaningful share of US ophthalmology over the past decade, and a credible business plan should acknowledge that directly rather than pretend it isn't happening. EyeCare Partners now operates with more than 1,000 providers across the country, per EyeCare Partners. American Vision Partners runs 137 locations across Arizona, Texas, New Mexico and Nevada with more than 180 doctors. Seoul Medical Group has become the single largest ophthalmology group in the US at 993 physicians across 234 locations, and academic systems such as Mass Eye and Ear Physicians — part of Massachusetts Eye and Ear and a Harvard Medical School teaching hospital — sit at 287 physicians in the same dataset, according to Definitive Healthcare.

That scale buys procurement power and marketing budget, not necessarily faster access or continuity of care — the two things patients and referring optometrists consistently say they want most. A new independent practice's real competitive position is speed to first appointment (weeks, not months), a named physician the patient sees again at every visit, and a referral relationship the local optometry community trusts. The plan should state this explicitly rather than leaving it implied.

The competitor-analysis section of the plan should name the actual consolidated groups and hospital systems operating in the target market, not describe "competition" in the abstract. A lender or investor reading the plan wants to see that the founder already knows who American Vision Partners or the local hospital-employed ophthalmology group is, and has a specific reason a patient would choose the new independent practice instead — shorter wait times, a named surgeon instead of a rotating panel, or a tighter relationship with the referring optometrist's own patients.

In the UK, NHS cataract-surgery waiting lists have pushed a growing share of self-funding and insured patients toward private ophthalmology referral routes, particularly around London, Manchester and Birmingham — a trend worth quantifying locally rather than assuming.

Demographics Driving Demand

The demand curve behind these numbers is almost entirely demographic. An estimated 3.8 million to 4.2 million cataract surgeries are performed annually in the United States, growing 3–4% a year, with projections pointing to roughly 4.4 million surgeries a year among the 65-plus population by 2030. More than half of Americans aged 80 or older already have cataracts or have had cataract surgery, and advanced age remains the single greatest risk factor for the disease. That's not a market a new practice needs to create from nothing — it's a market that already exists in every metro area and grows every year the local population ages, which is exactly why the referral relationships described above matter more than paid advertising in the first 18 months.

SBA Funding & Payer Credentialing

Two numbers matter more than any generic "get a small-business loan" advice: the SBA approval rate for the practice's exact NAICS code, and the number of days between opening day and the first insurance reimbursement landing in the bank account.

Ophthalmology practices file under NAICS 621111 (Offices of Physicians, except Mental Health Specialists), which the SBA classifies as a small business up to $16M in average annual receipts under the current size standards, per the U.S. Small Business Administration. Healthcare as a category posts some of the highest SBA 7(a) approval rates of any industry — typically in the 72–80% range for qualified applicants, according to Crestmont Capital — and the 7(a) program covers up to $5M for acquisitions, equipment, working capital or refinancing over terms as long as 10 years.

The number lenders and new owners both underestimate is credentialing lag. Medicare enrollment through PECOS typically runs 60–150 days, and commercial payer panels often run on similar or longer timelines in parallel. A practice that opens with four months of committed working capital but a five-month credentialing runway sets itself up for exactly the kind of cash-flow gap that breaches a loan covenant — not low patient volume, not equipment failure, just a forecast that assumed reimbursement would start on day one.

What a Lender Actually Wants to See

• A credentialing timeline built into the 12-month cash-flow forecast, not treated as a footnote
• Personal guarantor financials, including two years of the founder's W-2s or pay stubs from hospital or group employment
• A signed lease or letter of intent for the clinical space before the loan is underwritten
• Equipment quotes from named vendors (see below), not placeholder estimates
• A referral-pipeline narrative naming the optometry practices or physician groups expected to send the first patients

In the UK, the equivalent gap shows up differently: Start Up Loans (up to £25,000 at a fixed 6%) rarely cover ophthalmology-scale equipment on their own, so most UK founders combine a Start Up Loan with equipment leasing and a practice loan from a healthcare-specialist commercial lender.

Most first-time ophthalmology borrowers don't go to a generalist bank branch. Healthcare-focused lenders and platforms — the medical-practice lending desks at regional banks, and healthcare-specialist online lenders that underwrite specifically against NAICS 621111 cash-flow patterns — tend to move faster than a generalist small-business loan officer who has never underwritten a credentialing gap before. Debt-service coverage ratio (DSCR) is the metric that actually decides the loan, not the headline revenue projection: lenders want to see projected cash flow at 1.25x or better against the proposed debt service once credentialing is complete, which is precisely why the credentialing-adjusted cash-flow model matters more than an optimistic five-year growth curve.

What It Actually Costs to Open

Opening an independent, one-to-two-provider ophthalmology practice typically requires $250,000 to $700,000 (£198,000 to £553,000) in start-up capital, depending on how much diagnostic equipment is bought outright versus leased, and whether the space is a ground-up build-out or an existing medical suite. That range sits well below the multi-million-pound figures sometimes quoted for full ambulatory surgical centres — most new ophthalmologists open a comprehensive medical and diagnostic practice first, referring or co-managing complex surgical cases out until case volume justifies an in-house surgical suite.

Cost Breakdown

• Diagnostic and imaging equipment (OCT, fundus camera, visual field analyzer, slit lamp, autorefractor): $85K–$230K (£67K–£182K)
• Clinical premises lease and exam-lane build-out: $50K–$150K (£40K–£119K)
• Malpractice and general liability insurance (Year 1 premium): $18K–$55K (£14K–£43K)
• EHR / practice management software setup plus Year 1: $12K–$35K (£9K–£28K)
• Staffing ramp (ophthalmic technicians, front desk, billing) pre-breakeven: $35K–$90K (£28K–£71K)
• Marketing and referral-network development: $10K–$30K (£8K–£24K)
• Working capital buffer (3–6 months operating costs): $40K–$110K (£32K–£87K)

Funding Routes

In the US, SBA 7(a) loans, equipment financing offered directly through vendors like Zeiss and Alcon, and physician-specific practice loans from healthcare lenders cover most of this range. In the UK, Start Up Loans, occasional practitioner start-up grants, and commercial healthcare lenders are the common combination. Many founders also negotiate deferred equipment payment terms directly with Zeiss, Topcon or NIDEK sales teams, spreading the largest single line item over 3–5 years instead of paying it in full at closing.

Location moves the facility line more than any other input. Leasing clinical space in a suburban medical office park in a market like Greenville, South Carolina runs meaningfully less than a comparable build-out in a dense metro like Chicago or Los Angeles, where medical-grade tenant improvements alone can add $40K–$80K to the facility budget.

Regional Cost Variance

• Greenville, SC / mid-size Southeast metro: facility build-out typically toward the lower half of the $50K–$150K range; medical office park rents remain well below coastal-metro rates
• Chicago, IL / Los Angeles, CA: facility line commonly runs $40K–$80K above the national midpoint, driven by tenant-improvement labour costs and higher commercial rent per square foot
• Miami, FL / South Florida: equipment and staffing costs track close to the national midpoint, but malpractice premiums for surgical ophthalmology run meaningfully higher than the national average given the state's liability environment
• Smaller rural or micropolitan markets: facility and staffing costs fall toward the bottom of the range, but the referral-pipeline build takes longer because the local optometry base is smaller

Equipment & Software You'll Need

A new ophthalmology practice's capital equipment list is short compared to a full surgical centre, but it isn't optional — insurers and referring optometrists expect a baseline diagnostic set before they'll send patients.

Core Diagnostic Equipment

• Optical coherence tomography (OCT) system — Carl Zeiss Meditec remains the category leader with roughly a 23.2% revenue share of the diagnostic OCT segment, per Verified Market Research; a new-practice unit typically runs $60K–$120K
• Fundus camera and retinal imaging — Topcon and NIDEK both sell practice-scale non-mydriatic units
• Automated visual field analyzer for glaucoma monitoring
• Slit lamp biomicroscope and applanation tonometer per exam lane
• Autorefractor/keratometer for the refraction workflow
• Heidelberg Engineering's Spectralis platform for combined retina and glaucoma imaging where case mix justifies the added cost
• Alcon phacoemulsification and surgical instrumentation once the practice adds in-house cataract surgery — typically financed rather than purchased outright at launch

Practice Management & EHR Software

Ophthalmology billing is unusually complex — evaluation-and-management codes, eye codes and surgical modifiers all interact — which makes a specialty-built system worth the premium over a generic EHR.

• ModMed EMA — an ophthalmology-specific EHR with AI-assisted charting, consistently among the highest-rated systems for ophthalmology users, per ModMed
• NextGen Healthcare — an ophthalmology-tuned EHR that reports saving providers up to 2.5 hours a day on documentation, per NextGen
• Compulink Advantage SMART Practice — combined practice management, EHR, optical retail and surgery-centre interface in one system
• Eyefinity OfficeMate — cloud practice management with strong optical-dispensary and billing tools, often paired with a separate clinical EHR

Budget $12K–$35K for software licensing, implementation and staff training in Year 1; ongoing monthly subscriptions typically run $300–$900 per provider depending on the vendor and module set.

Buy, Lease or Wait

Not every item on the diagnostic list needs to be purchased outright at launch. A practical sequencing most new practices follow: buy the slit lamp, tonometer and autorefractor outright (they're relatively inexpensive and used on every single patient); lease the OCT and visual field analyzer through the manufacturer's financing arm, since both Zeiss and Topcon offer practice-stage leasing that keeps the equipment line off the initial capital ask; and wait on anything surgical — phacoemulsification systems, femtosecond lasers — until case volume from the referral pipeline actually justifies the spend. Practices that buy the full surgical suite before opening day are usually the ones carrying idle capital equipment through their first slow year.

A realistic Year 1 equipment spend for a comprehensive, non-surgical launch — one slit lamp per exam lane, one tonometer, one autorefractor, one leased OCT and one leased fundus camera — lands closer to $95K–$140K in cash outlay once lease structuring is factored in, versus $230K+ if every item on the diagnostic list is purchased outright. That gap is often the difference between needing a $340K raise and needing a $500K one, which is exactly why the equipment schedule belongs in the same model as the funding ask, not in a separate appendix nobody cross-checks against the cash-flow forecast.

How the Practice Makes Money

Ophthalmology revenue comes from three fairly distinct buckets, and a credible plan forecasts each one separately rather than blending them into a single average "per patient" number:

• Medical and diagnostic visits (comprehensive exams, glaucoma and retina follow-ups, diabetic eye exams) billed to Medicare and commercial insurance, averaging roughly $200 per encounter
• Surgical and procedural revenue — cataract surgery, YAG capsulotomy, minor lid procedures — where combined professional and facility fees run $1,800–$3,500 per case depending on complexity and site of service
• Optical dispensing (glasses, contact lenses, premium lens upgrades) with a typical net margin of $150–$300 per pair after cost of goods

A Worked Example

A solo comprehensive ophthalmologist seeing 20 patient encounters across 4 clinical days a week, 48 weeks a year, generates roughly 3,840 encounters at an average $200 per encounter — about $768,000 in medical revenue before a single surgical case. Layer in an in-house optical dispensary at a 15% attach rate (576 pairs at an average $280 net per pair, roughly $161,000) and Year 1 revenue lands close to $929,000. At a conservative 30% first-year margin that's roughly $279,000 in owner earnings before surgical volume ramps. By Year 3, as cataract and refractive case volume builds toward 300–400 cases a year at $1,800–$3,500 per case, total practice revenue commonly reaches $1.5M–$2M with 35–45% margins — consistent with the reported owner take-home below.

The part most templates skip is what happens between opening day and that $929,000 annualised run rate. If credentialing takes the full 150 days, the first five months of encounters are effectively self-pay or already-credentialed-payer only — realistically 30–40% of the eventual steady-state volume. That means the working-capital buffer isn't a nice-to-have line item; it's what covers payroll, rent and equipment lease payments while the bulk of the revenue is still sitting in a payer's credentialing queue rather than in the bank.

Anterior-segment private ophthalmology practices commonly land at 30–45% net margin once credentialing is complete and case volume stabilises; practices with a heavier managed-care payer mix or higher overhead sometimes run closer to 20%, while highly efficient single-specialty practices reach 45–50%. Reported owner take-home for established single-owner ophthalmology practices runs $450,000–$800,000, broadly consistent with median ophthalmologist total compensation of $670,000 reported for 2026.

The 2026 Reimbursement Shift You Need to Model

Any revenue forecast built on last year's Medicare numbers is already out of date. The Calendar Year 2026 Medicare Physician Fee Schedule final rule sets two conversion factors — $33.4009 for physicians outside a qualified alternative payment model and $33.5675 for those inside one — but the headline number hides a much bigger story for ophthalmology specifically. Facility-based cataract surgery (CPT 66984) takes an 11% cut to the surgeon's payment, the largest single reduction to that code in three decades. YAG capsulotomy (CPT 66821) and panretinal photocoagulation (CPT 67228) see even steeper facility-based reductions. At the same time, procedures performed in the office setting see modest increases relative to the facility setting, part of a deliberate site-of-service rebalancing in the final rule.

For a business plan, this changes the forecast in a concrete way: a practice modelling its Year 2–3 surgical ramp purely on today's ambulatory-surgical-centre fee schedule is overstating future revenue, while a practice that builds an office-based procedure pathway into its plan from the start captures the upside of the same rule. This is exactly the kind of detail a generic business plan template has no way of including, because it changes every year and has to be pulled from the current CMS final rule, not last year's guide.

Getting Licensed: US, UK & Australia

Licensing is usually the longest lead-time item in the whole launch plan — often longer than the lease negotiation or the equipment build-out. The clinical licensure itself (medical school through residency and board certification) is usually complete before a founder ever writes a business plan; what actually sits on the critical path for a new practice is everything downstream of that: state facility rules, CLIA, DEA, malpractice binding, and payer enrollment. Treat these as a single project-managed sequence with named agencies and target dates, not a checklist to revisit "once things settle down."

United States

• State medical board licensure (MD/DO) plus American Board of Ophthalmology certification, requiring four years of medical school, a one-year internship and a three-year ophthalmology residency before the licensing exam
• CLIA certificate for any in-office lab testing — only the TearLab Osmolarity test and the AdenoPlus adenovirus test currently qualify for a CLIA Certificate of Waiver in ophthalmology, and California, Nevada and New York restrict who may hold a waiver, per the American Optometric Association's CLIA guidance
• Medicare/Medicaid provider enrollment through PECOS
• Malpractice insurance ($1M/$3M minimum, higher for surgical scope)
• HIPAA compliance certification
• OSHA bloodborne pathogen compliance

United Kingdom

• GMC registration with a licence to practise and entry on the Specialist Register for ophthalmology, with revalidation every five years
• CQC registration for regulated activities such as surgery and diagnostic or screening procedures — a single-site, single-specialty clinic pays £1,743 a year, per Team Care Compliance; operating a regulated activity before registration is a criminal offence
• Professional indemnity insurance, typically £10M+ of cover for surgical ophthalmology
• Employers' liability insurance
• Enhanced DBS check
• Clinical waste disposal licence and GDPR/information governance compliance

Australia

Australia adds a step most US and UK founders don't expect: registration and reimbursement sit with two different bodies. AHPRA registration — through the Vocational Register or general registration with specialist recognition — has to be in place before Services Australia will issue a Medicare provider number, per Services Australia. Applicants need a PRODA account and HPOS access to apply online, and every practice location requires its own separate provider number — a multi-site practice can't reuse one number across clinics. RANZCO fellowship remains the standard route to specialist recognition.

The practical cost of getting any of this wrong is rarely a fine — it's a delayed opening. A CQC application submitted with the wrong regulated-activity scope, a CLIA waiver assumed but never filed, or a PECOS enrollment started after the lease is signed instead of before, each routinely add 30–60 days to a launch timeline that was already tight. The licensing section of the plan should read as a project-management timeline with named agencies and realistic dates, not a bullet list of things to "look into."

Five Mistakes That Sink First-Year Practices

Almost none of the ophthalmology practices that struggle in Year 1 fail because demand wasn't there — the demographic tailwind described earlier is real in nearly every metro area. They fail because the plan and the cash-flow model were built around an assumption that turned out to be wrong on day one, usually one of these five.

• Buying top-tier equipment before proof of volume. A $150K+ swept-source OCT or a femtosecond laser purchased before referral volume is validated ties up capital that should be funding the credentialing runway; start with core diagnostics and add capital equipment once case volume justifies it.
• Underestimating the credentialing timeline. Treating the 90–150 day Medicare and commercial payer credentialing window as a rounding error, rather than the single biggest driver of the cash-flow forecast, is the most common reason new practices run out of working capital in month three or four.
• Underpricing premium self-pay services. Competing with PE-backed regional chains such as TLC Laser Eye Centers on price for LASIK or premium IOLs is a losing game; independent practices win on outcomes, continuity and the surgeon the patient actually sees again.
• Skipping the co-management pipeline. Referral relationships with local optometrists take 6–12 months to mature and should be built before opening day, not after the first slow quarter.
• Treating coding as an afterthought. Ophthalmology's mix of evaluation-and-management codes, eye codes and surgical modifiers drives high denial rates when billing staff and software aren't set up correctly from day one — a problem that shows up as a cash-flow crisis three months after it was actually created.

A Realistic 12-Month Launch Sequence

Most of the mistakes above trace back to sequencing, not effort. A launch timeline that survives contact with reality generally looks closer to this:

• Months 1–2: lease negotiation, SBA or Start Up Loan application, and the first round of optometrist referral-relationship conversations, run in parallel rather than sequentially
• Months 2–4: PECOS/Medicare enrollment and commercial payer credentialing filed the moment the lease is signed, not after the fit-out is finished
• Months 3–5: clinical build-out, core diagnostic equipment delivery, and EHR/practice-management implementation and staff training
• Months 4–6: soft opening on self-pay and already-credentialed payers while remaining credentialing applications finish processing
• Months 6–9: full opening once the bulk of payer panels are active; referral volume from the optometry network should be ramping by this point
• Months 9–14: operating break-even, typically once encounter volume and payer mix both reach steady state

What a Finished Plan Looks Like

Every Avvale ophthalmology plan includes a full financial model behind the narrative below. Here's a condensed excerpt of the kind of executive summary a buyer receives.

Every Section Included in Your Template

Every Avvale business plan template includes these sections, pre-structured for an ophthalmology practice launch:

• Executive Summary — the practice at a glance, written to hook a lender or investor in 60 seconds
• Company Overview — legal structure, ownership, location, and founding story
• Industry Analysis — market size, growth trends, and the regulatory timeline specific to ophthalmology
• Patient & Referral Analysis — target patient segments, co-management strategy, and vision-plan mix
• Competitor Analysis — local competitive mapping against independents and consolidated groups, and your differentiation strategy
• Marketing Plan — referral-channel development, digital presence, and patient acquisition strategy
• Operations Plan — day-to-day workflows, staffing structure, equipment schedule, and key milestones
• Management Team — founder bio, advisory board, and key hires planned

The optional Financial Forecast add-on (included in our $300/£250 and $1,000/£800 packages) provides a 5-year Excel model with income statement, cash flow, balance sheet, break-even analysis, and a credentialing-lag-adjusted startup capital schedule.

For the Research + Content and Bespoke packages specifically, we build the payer-credentialing timeline and the 2026 Medicare Physician Fee Schedule site-of-service assumptions directly into the cash-flow model rather than leaving them as a narrative footnote — the same approach used in the worked example and case study on this page. That's the difference between a plan that reads well and a plan a lender's underwriter actually approves.

Related reading: our eye care clinic business plan template and optometrist business plan template cover the adjacent, non-surgical side of the vision-care market if that's a closer fit.

Frequently Asked Questions

Keep Reading

More Avvale resources relevant to an ophthalmology practice launch:

• Work with an Avvale business plan writer if you'd rather talk it through before committing to a package
• Eye care clinic business plan template for a broader vision-care launch
• Optometrist business plan template for the non-surgical, OD-led version of this plan
• Priority Healthcare Plus Ltd case study — a related Avvale healthcare launch